National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2017 (No. 4) (PB 38 of 2017) (Cth)

PB 38 of 2017

National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2017 (No. 4)

National Health Act 1953

I, PENNY SHAKESPEARE, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated 30 May 2017

PENNY SHAKESPEARE

First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health

___________________________________________________________________________

Amendment instrument – Pharmaceutical benefits – early supply

1          Name of Instrument

(1)      This Instrument is the National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2017 (No. 4)

(2)This Instrument may also be cited as PB 38 of 2017.

2          Commencement

This Instrument commences on 1 June 2017.

3          Amendment of PB 120 of 2015

Schedule 1 amends the National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015).

Schedule 1        Amendments

1. Schedule 1

omit:

Brentuximab vedotin Powder for I.V. infusion 50 mg 20 200 11

1. Schedule 1

omit:

Colestipol	Oral powder, sachets containing colestipol hydrochloride 5 g, 120	20	1	5
Colestipol	Oral powder, sachets containing colestipol hydrochloride 5 g, 120	20	1	11

1. Schedule 1

omit:

Rosiglitazone Tablet 8 mg (as maleate) 20 28 5

1. Schedule 1, after entry for Ruxolitinib in the form Tablet 20 mg [Maximum Quantity: 56; Number of Repeats: 5]

insert:

Sacubitril with valsartan	Tablet containing sacubitril 24.3 mg with valsartan 25.7 mg	20	56	5
Tablet containing sacubitril 48.6 mg with valsartan 51.4 mg	20	56	5
Tablet containing sacubitril 97.2 mg with valsartan 102.8 mg	20	56	5

1. Schedule 1, entry for Vismodegib

omit from the column headed “Maximum number of repeats”:         2        substitute:    3